Valtech:2025年制药公司在欧盟数据法案时代的胜算白皮书(英文版).pdf |
下载文档 |
资源简介
The EU Data Act (EDA) isn’t just another regulation. It’s a structural reset in the way pharma companies create, share and monetize value. By September 2025, every pharma organization operating in Europe will be accountable to a fundamentally different data regime. Control over patient-generated data will become central to commercial leadership, not just compliance. The EDA reshapes the rules of data ownership and access. It breaks down closed systems in favor of ecosystem-enabled value creat
本文档仅能预览20页